Gossamer Bio, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Gossamer Bio is holding a special meeting of stockholders to vote on several proposals, including an exchange offer for its convertible notes, an amendment to its incentive award plan, and an increase in authorized shares.
NASDAQ
Gossamer Bio, Inc. has issued its 2026 proxy statement detailing director elections, executive compensation, and auditor ratification for the upcoming annual meeting.
NASDAQ
DEFA14A: Gossamer Bio Seeks Shareholder Approval for Auditor Ratification at Upcoming Annual Meeting
Gossamer Bio is holding its annual meeting and seeking shareholder ratification of Ernst & Young LLP as its independent auditor for the year ending December 31, 2020.
NASDAQ
Gossamer Bio sets June 25, 2025, for its annual stockholder meeting and proposes an amendment to its 2019 Incentive Award Plan.
NASDAQ
DEFA14A: Gossamer Bio Seeks Shareholder Approval for Auditor Ratification at Upcoming Annual Meeting
Gossamer Bio is holding its annual meeting and seeking shareholder ratification of Ernst & Young LLP as its independent auditor for the year ending December 31, 2020.
NASDAQ
Gossamer Bio will hold its annual stockholders meeting virtually on June 6, 2024, to vote on director elections, auditor ratification, and executive compensation.